PLUS1
1.09
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Premarket
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Atossa Therapeutics Inc | ATOS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| 0.00 | 0.0% | 1.09 | 04:02:52 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.09 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.8351 - 7.15 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 1.09 | USD |
Period:
Draw Mode:
Atossa Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 138.02M | 126.62M | 126.57M | $ - | $ - | -0.18 | -6.40 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 250.00k | 0.40% |
Atossa Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ATOS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.11 | 1.24 | 1.08 | 1.17 | 4,237,935 | -0.02 | -1.8% |
| 1 Month | 0.95 | 1.36 | 0.9306 | 1.13 | 2,381,152 | 0.14 | 14.74% |
| 3 Months | 1.17 | 1.36 | 0.8351 | 1.07 | 1,827,622 | -0.08 | -6.84% |
| 6 Months | 1.63 | 1.80 | 0.8351 | 1.24 | 1,987,345 | -0.54 | -33.13% |
| 1 Year | 6.15 | 7.15 | 0.8351 | 3.29 | 4,568,848 | -5.06 | -82.28% |
| 3 Years | 2.54 | 9.80 | 0.755 | 3.35 | 5,326,305 | -1.45 | -57.09% |
| 5 Years | 6.00 | 19.08 | 0.755 | 3.96 | 4,004,089 | -4.91 | -81.83% |
Atossa Therapeutics Description
| Atossa Therapeutics Inc is a clinical-stage pharmaceutical company operating in us. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use. |
